Covert killer
story Libby Whittemore | photo Ben Mangin
Forty-year-old Laura Calappi first heard the words “inflammatory breast cancer” after a 2004 doctor’s appointment in which the appearance of her breast so sincerely baffled her surgeon that he requested permission to take a picture. A few weeks prior, Calappi had discovered a growth on the outside of her breast that she thought might be dermatitis, an ingrown hair, or even a bug bite. A biopsy of the growth, which bled and crusted at times, came back positive for IBC.
Inflammatory Breast Cancer is an acutely aggressive but seldom publicized disease. This rare and elusive cancer variety metastasizes in sheets, or what oncologists call “nests.” In other words, IBC doesn’t clot in lumps, doesn’t show up in mammograms, and can’t be detected by breast self-examination. And, it’s striking victims as young as sixteen.
IBC comprises less than one percent of all cancer diagnoses, says Dr. Steven Chui, an oncologist at Oregon Health and Science University in Portland, Oregon. Chui sees between six and eight cases every year. Although Calappi is now healthy, she is a statistical minority. “IBC in particular really pisses me off,” Chui says, “because two-thirds of women with IBC will be dead in three years.”
